NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based on a proprietary Artificial Immune Modulation (AIM) nanotechnology platform, announced that industry veterans Han Myint, MD has been appointed as the Company’s Chief Medical Officer. Additionally, John Trainer, MBA has been appointed as the Chief Financial Officer.
Image: https://biobuzz.io
{iframe}https://biobuzz.io/neximmune-appoints-industry-veteran-chief-medical-officer-to-executive-team/{/iframe}